Toggle Main Menu Toggle Search

ePrints

Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery

Lookup NU author(s): Salah Abohelaika, Dr Hilary Wynne, Dr Peter Avery, Professor Farhad Kamali

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

BackgroundPatients on warfarin are normally required to stop treatment for a fixed number of days prior to an invasive procedure. However, the anticoagulant activity of warfarin subsides at different rates among different patients.ObjectivesThe aim of this study was to investigate the potential influence of CYP2C9 polymorphism on the variable rate of fall in the International Normalized Ratio (INR) in patients withdrawing from warfarin treatment prior to elective surgery.Patients/MethodsOne hundred and fifty-two patients aged 43-93years were recruited. Demographic data on age, height, weight, gender, daily warfarin dose, indication for anticoagulation therapy, medical diagnosis, surgical operation planned and concomitant medication were recorded. A blood sample was taken for later CYP2C9 genotyping.ResultsFor patients with two CYP2C9 variant alleles (CYP2C9*2*2 or CYP2C9*2*3), the odds of having an INR of 1.5 before the planned day of surgery were 8.64 times greater (95% confidence interval [CI]2.25-33.25) than for other patients. Multiple regression analysis revealed that the rate of fall in the INR was reduced in the presence of two CYP2C9 variant alleles, as well as increasing patient age, weight and number of comorbidities, and increased with increasing initial INR (F-5,F-132=242.9, P<0.0001), all of which accounted for similar to 90% of the interindividual variability in the fall in INR.ConclusionA genotype-guided protocol to tailor warfarin withdrawal according to an individual patient's CYP2C9 genotype could reduce cancellation or delays of planned procedures, and could also be beneficial when transitioning patients from warfarin to one of the new oral anticoagulants.


Publication metadata

Author(s): Abohelaika S, Wynne H, Avery P, Kamali F

Publication type: Article

Publication status: Published

Journal: Journal of Thrombosis and Haemostasis

Year: 2015

Volume: 13

Issue: 8

Pages: 1436-1440

Print publication date: 01/08/2015

Online publication date: 19/06/2015

Acceptance date: 13/05/2015

ISSN (print): 1538-7933

ISSN (electronic): 1538-7836

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/jth.13014

DOI: 10.1111/jth.13014


Altmetrics

Altmetrics provided by Altmetric


Actions

    Link to this publication


Share